Document n9kBjB99vNxqOML3B1B7OGQbR

P-O 000220 ) onti -tmtyv From: To: Barbara J Dawson on 10/19/2000 1201 PM Beth F Basham/AE/DuPont@DuPont. Aaron Chen/AHOuPont@DuPont, Michael J Daty/AE/DuPont@DuPonL Nicholas J OeStefano/AE/DuPont@OuPont. Mary Ann Hayes/DuPont@OuPont, James R Kotersld/AH/DuPont@DuPont, Irena A Legiec/AE/DuPonl@DuPont. Richard J Ubutti/DuPont@DuPorrt, Douglas A Paine/AH/DuPont@DuPont. Michael L Szep/AE/DuPont@DuPont bjecl: C8 Follow -up Medical Surveillance Just wanted to le t everyone know that we plan to do the follow-up m edical surveillance for the people who participated in the baseline study fast year. Beginning next week, we w ill be asking each unit to schedule their people fo r an appointment in Medical on Wednesday, Thursday cr Friday by calling Les Bacon. Note that Medical is not yet fully functional as a result o f th e ir relocation and that th is note is relative only to C8 follow-up surveillance. Forty three people participated In the baseline surveillance which included: medical history questionnaire automated chemistry profile (analysis by LabCorps) - SMA-12 (includes HQL, cholesterol, glucose, uric acid. BUN. calcium, pbosphonis, total protein, albumin, bilirubin, alkaline phosphatase, LDH, AST (SGOT), total cholesterol, creatinine and ALT (SGPT)) complete blood count (analysis by LabCorps) perfluorooctanoic acid (PFOA) In blood (analysis by National M edical Services, W illow Grove, PA} 9 total fluorine in blood (analysis by Chris Bowers? lab in Jackson Lab) The follow-up surveillance w ill be identical to the baseline surveillance and each person's results w ill be compared his/her baseline, i am also working w ith the unit S&OH coordinators to identify others who need the baseline surveillance - these people are not included in the following list. W e plan to do the follow-up on alt o f the original participants, whether o r not they worked in the process. A decision still needs to be made relative to the people who are no longer on the site. An email message w ill be sent to each participant on Monday with copies to their unit manager and S&OH coordinator inform ing them of the program. I w ill forward a copy o f the draft le tte r in another m essage. I recommend that you talk to the employees before they receive the email so that they know it is coming. W orkers In the surveillance w ilt include: Name S h ift A re a S ta tu s A JLTech A JL Tech A O peratoci205 m edfcalM ech/P P W never worked in process A Mech/PPW A Operator/1205 B Operator/1205 B Operator/1205 B Mech/PPW never worked in process B JL Technician B JL Technician B* Operator/1205 C JL Technician C Mech/PPW C Mech/PPW c Operator/1205 c JL Technician c Operator/1205 ` REDACTED" Company Sanitized. Does not contain T S C A C B i 000221 D D D D Day Day (12) Day Day Day Day Day Day Day Day Day Day Day Day Day JL Technician O perator/1205 JL Technician Operator/1205 Engineer/1205 JL Technician E le c/P P W Mech/PPW JL Technician JL Technician M ech/PP W FLS/PPW Mech/PPW JL Technician Mech/PPW JL Chemist Engineer/PPW JL Chemist JL Technician neverw o rke d ^ process now iiM M M j2 4 now inK 37 never worked in process Operator/1205 - Mech/PPW JL Chemist JL Technician retired retired transferred pensioned Prior to their v isit, everyone should receive a copy o f the medical history interval form and bring the completed form w ith them when they come to M edical, I w ill give copies to John Plum for the PPW workers and to Aaron Chen fo r the JL workers. ` REDACTED* Com pany Sanitized. Does not contain T S C A CBI 000222